Key Details
Price
$0.90Annual ROE
-136.47%Beta
2.62Events Calendar
Next earnings date:
Mar 13, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Mar 13, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 27, 25 HC Wainwright & Co.
BuyJan 23, 25 Truist Securities
BuyJan 2, 25 HC Wainwright & Co.
BuyDec 31, 24 Wells Fargo
Equal-WeightDec 31, 24 Jefferies
BuyDec 20, 24 HC Wainwright & Co.
BuyDec 19, 24 HC Wainwright & Co.
BuyDec 10, 24 HC Wainwright & Co.
BuyNov 14, 24 HC Wainwright & Co.
BuyNov 14, 24 Barclays
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Sangamo Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Sangamo Therapeutics?
- Does Sangamo Therapeutics pay dividends?
- What sector is Sangamo Therapeutics in?
- What industry is Sangamo Therapeutics in?
- What country is Sangamo Therapeutics based in?
- When did Sangamo Therapeutics go public?
- Is Sangamo Therapeutics in the S&P 500?
- Is Sangamo Therapeutics in the NASDAQ 100?
- Is Sangamo Therapeutics in the Dow Jones?
- When was Sangamo Therapeutics's last earnings report?
- When does Sangamo Therapeutics report earnings?
- Should I buy Sangamo Therapeutics stock now?
What is the ticker symbol for Sangamo Therapeutics?
The ticker symbol for Sangamo Therapeutics is NASDAQ:SGMO
Does Sangamo Therapeutics pay dividends?
No, Sangamo Therapeutics does not pay dividends
What sector is Sangamo Therapeutics in?
Sangamo Therapeutics is in the Healthcare sector
What industry is Sangamo Therapeutics in?
Sangamo Therapeutics is in the Biotechnology industry
What country is Sangamo Therapeutics based in?
Sangamo Therapeutics is headquartered in United States
When did Sangamo Therapeutics go public?
Sangamo Therapeutics's initial public offering (IPO) was on April 6, 2000
Is Sangamo Therapeutics in the S&P 500?
No, Sangamo Therapeutics is not included in the S&P 500 index
Is Sangamo Therapeutics in the NASDAQ 100?
No, Sangamo Therapeutics is not included in the NASDAQ 100 index
Is Sangamo Therapeutics in the Dow Jones?
No, Sangamo Therapeutics is not included in the Dow Jones index
When was Sangamo Therapeutics's last earnings report?
Sangamo Therapeutics's most recent earnings report was on Nov 12, 2024
When does Sangamo Therapeutics report earnings?
The next expected earnings date for Sangamo Therapeutics is Mar 13, 2025
Should I buy Sangamo Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions